about
Management of adjuvant mitotane therapy following resection of adrenal cancer.Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma.Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer.RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization.Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer.Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma.Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines.CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells.Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas
P50
Q38019388-BEB13821-F7BE-48A1-BD2B-EEF7598F09ADQ38713191-8E305A11-EE28-4451-B0C2-C9FBBA286185Q38825846-CC987396-DC99-491B-97A9-C6E748F38D08Q38929781-9E2AE6E4-49B9-439C-8BC2-3FBAD49FC85CQ39175368-BEEA48DE-3DC8-45B5-A723-F0F626D61B1BQ39355860-51CD1888-2114-45B8-B1FB-7D39C505D352Q39424270-535CBF7C-7E9C-48FC-94DF-9C80CE1DE85BQ44976789-0790F676-E16F-4C3B-B8CC-2328F36DB17CQ55091442-3BC338E5-065F-4E1C-9D9F-D7B6577C0E7AQ88182715-EFAA7955-868E-4EBE-BFBC-3356490A2A70
P50
description
researcher ORCID ID = 0000-0002-6488-7814
@en
wetenschapper
@nl
name
Antonina Germano
@ast
Antonina Germano
@en
Antonina Germano
@es
Antonina Germano
@nl
type
label
Antonina Germano
@ast
Antonina Germano
@en
Antonina Germano
@es
Antonina Germano
@nl
prefLabel
Antonina Germano
@ast
Antonina Germano
@en
Antonina Germano
@es
Antonina Germano
@nl
P106
P1153
55067124500
P31
P496
0000-0002-6488-7814